Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Phoenix Sleep is a plant-based pharmaceutical product developed by Phoenix Life Sciences International Limited, specifically designed for the treatment of sleep disorders and the induction of sedation. As part of a specialized portfolio of botanical therapies, it utilizes active ingredients extracted from organically produced plants, including cannabis-derived cannabinoids. These extracts are encapsulated using proprietary technology intended to optimize bioavailability and therapeutic efficacy. The drug's mechanism focuses on addressing underlying physiological deficiencies and promoting homeostasis by interacting with the body's endocannabinoid system to regulate sleep-wake cycles. Phoenix Sleep represents a move toward standardized, plant-derived alternatives to synthetic sedative-hypnotics.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on Phoenix Sleep.